Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
RABIES VACCINE BP– PRECAUTIONARY RECALL OF TWO BATCHES
Notice type:
Recall
Date:
07/04/2004
Product name or type:
RABIES VACCINE BP
Product Classification:
Vaccine
Serial Or Batch Number And Expiry Date:
X0712-1 and X0071-6
Authorisation Holder:
Aventis Pasteur MSD Limited
Problem Or Issue:
The Irish Medicines Board (IMB) stated today that it is in close consultation with the French regulatory authorities and Aventis Pasteur MSD Limited in relation to the worldwide recall of a rabies vaccine manufactured by the company’s operations in France.
This recall is as a precautionary measure following a recent test at the company, which revealed a low level of contamination with live weakened rabies virus in a single batch. This batch was rejected by the company and never released to the market.
The IMB states that the company is carrying out a recall of all batches of rabies vaccine manufactured at that facility at that time as a maximum precautionary measure and that the risk of potential harm ranges somewhere between nil to negligible. The IMB confirms that this rabies vaccine has been licensed for use in Ireland since 1994 and that two specific batches have been recalled from the Irish market. These two batches are numbered X0712-1 and X0071-6 and were marketed in Ireland between the 24th October 2003 and 2nd April 2004. These batches passed all European and US release procedures before being released onto the Irish market.
The IMB states that an alternative source for this vaccine is licensed in Ireland and sufficient supplies are being made available at this time in order to meet the demand.
The IMB advises that they are in contact with the National Disease Surveillance Centre (NDSC), Department of Health and Children (DoHC) and relevant national and international experts in this area. Relevant healthcare professionals are also being advised on the situation.
Any person who received the rabies vaccine after October 24th 2003, should not be unduly concerned as this is a precautionary recall but are advised to contact the doctor/travel centre that administered their vaccine for further advice and to determine whether they may have received the vaccine from a recalled batch.
A question and answer document for the public and healthcare professionals is available on the HPRA and NDSC websites @
www.hpra.ie
and
www.ndsc.ie
Background Information Or Related Documents:
RABIES VACCINE BP– PRECAUTIONARY RECALL OF TWO BATCHES Document
Actions To Be Taken:
FAQ For Healthcare Professionals and Patients:
Healthcare Professional Data relating to this product
Further Information:
Siobhan Molloy/Jackie HendersonWeber Shandwick FCC
Tel: (01) 676 01 68 or 086 817 50 66
« Back
Date Printed: 26/04/2024